CPR Launches New Disease Silo to Support Patients Diagnosed with Lipodystrophy.
Hampton, VA, June 2, 2014 – Patient Advocate Foundation (PAF) announced today the expansion of its Co-Pay Relief (CPR) program with the opening of the Inherited or Acquired Lipodystrophy disease silo. Patients diagnosed with a Lipodystrophy condition face localized or wide-spread loss of fat cells within their tissue, which can lead to severe metabolic complications and insulin resistance. Opened on June 2, 2014, this CPR program silo provides qualified patients with financial grants of up to $10,000 towards their pharmaceutical co-payments. “This new fund will greatly help insured patients who are struggling to afford their medication costs associated with treatment and therapy related to their diagnosis of Lipodystrophy,” stated Fran Castellow, MSEd, President of Operations for PAF and the Co-Pay Relief Program.
“Insured patients typically face significant drug copayments and out of pocket costs that may prevent them from getting the treatment they need to combat this disease. We are confident these funds will allow more Lipodystrophy patients to access the medications they need,“ added Alan Balch,PhD, CEO of Patient Advocate Foundation. The Inherited or Acquired Lipodystrophy Silo is the first copayment assistance program in the country that addresses the high costs associated with an insured patient’s cost responsibility associated with treatment of this condition.
To be eligible for support, patients must have an income of 400% or below the Federal Poverty limit and must be diagnosed with an inherited or acquired disorder. The CPR program provides qualified applicants to this fund with up to $10,000 per year in grant support towards the required co-payments and co-insurance for the pharmaceutical treatments and therapies associated with their diagnosis of a Lipodystrophy. To learn more or begin an application, patients can visit www.copays.org/diseases/lipodystrophy or call a trained application specialist at 866-512-3861.